Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic v. Guidant

This article was originally published in The Gray Sheet

Executive Summary

Delaware federal court reverses prior patent infringement ruling against Medtronic's Driver and S7 coronary stents, Medtronic announces Feb. 2. The initial ruling, issued Jan. 5, found that Medtronic's products infringed one of Guidant's Lau patent claims (1"The Gray Sheet" Jan. 10, 2005, p. 3). On Feb. 7, a jury trial is scheduled to review Medtronic's claim that the Lau patents are invalid...

You may also be interested in...

Medtronic Stent Patent Ruling Makes DES Vulnerable; Will Guidant Cut Deal?

Medtronic will appeal a Delaware federal court patent infringement ruling against its Driver and S7 coronary stents and challenge the validity of Guidant's Lau patent, the firm says

BrightGene Bets On Remdesivir Amid Patent Questions

Despite many uncertainties, Suzhou-based BrightGene sees a bet on generic remdesivir worthy of a $700,000 investment.

QUOTED. 17 February 2020. Ralph Ives.

The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.   




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts